Alethia Biotherapeutics is Drug Discovery in Canada that focus on cancer-associated epithelial business. Founded in 2002. They cover business area such as developer, monoclonal antibody therapeutic, clinically relevant disease-specific target, patent STAR discovery technology, invasive carcinoma, mesenchymal, healthcare professional, their patient, cancer.
2002
( 22 years old in 2024 )
Cancer-associated Epithelial
-
141, President-Kennedy Avenue
Suite SB-5100
Montreal, Quebec H2X 1Y4
Canada
Private
developermonoclonal antibody therapeuticclinically relevant disease-specific targetpatent STAR discovery technologyinvasive carcinomamesenchymalhealthcare professionaltheir patientcancer
* We use standard office opening hours in near Alethia Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alethia Biotherapeutics is Drug Discovery business from Canada that founded in 2002 (22 years old in 2024), Alethia Biotherapeutics business is focusing on Cancer-associated Epithelial.
Alethia Biotherapeutics headquarter office and corporate office address is located in 141, President-Kennedy Avenue Suite SB-5100 Montreal, Quebec H2X 1Y4 Canada.
Alethia Biotherapeutics was founded in Canada.
In 2024, Alethia Biotherapeutics is currently focus on cancer-associated epithelial sector.
Above is snippet of Google Trends for "cancer-associated epithelial" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alethia Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
